qPCR

Aegea Biotechnologies is a life science company in San Diego, CA, focused on nucleic acid technologies for molecular diagnostics. Its patented Switch-Blocker™ chemistry suppresses wild-type DNA and selectively amplifies rare mutations, enabling detection of genetic variants below 0.01% for PCR, NGS, and microarray applications. The company holds 11 issued U.S. patents and offers research-use-only kits and custom assay development.

analytical performance benchmarkingassay design and validationcustom assay developmentMicroarraynext-generation sequencing (NGS)PCR

Alamar Biosciences, Inc. is a proteomics company based in Fremont, California, that develops technologies for protein biomarker detection. Its offerings include the ARGO HT System, an all-in-one automated instrument with onboard qPCR, and NULISA assays for immunology, neurology, and oncology, along with custom assay development and data analysis solutions.

automationcustom assay developmentdata analysismultiplex biomarker analysisNGSproteomicssingle-plex assays

Alpha Genesis is an AAALAC-accredited, USDA-licensed preclinical research and animal-resource partner supporting pharmaceutical, biotechnology, academic, and government sponsors. It designs and executes preclinical development programs across rodent and nonhuman primate models, from pharmacology and PK/PD through toxicology, bioanalysis, and IND-enabling work, and operates the largest NHP colony in the United States with 13,000+ NHPs across three facilities.

bioanalysiscatheterizationdevice implantationFlow CytometryhistologyIHCimmunoassaysin vivo researchISH/RNAscopeLC-MS/MSmicrosurgeryMRIpathologyPET/CT imagingpharmacologyPK/PDSPECT/CT imagingtelemetrytoxicology

Applied Biological Materials Inc. (abm) is a biotechnology company providing products and services for molecular biology, cell biology, and genetic engineering. abm offers PCR, qPCR, RT-PCR, immortalized and stable cell lines, primary cells, lentivirus, AAV, adenovirus, CRISPR knockout cell lines, Cas9, sgRNA, siRNA, miRNA, antibodies, and proteins, plus custom cell and organoid services.

AAV packagingadenovirus packagingcell immortalizationCRISPR knockout cell line generationcustom cloninggene synthesisIHC stainingiPSC reprogrammingLentivirus packagingorganoid developmentPCRretrovirus packagingRT-PCRstable cell line generationtissue microarray

BioModels is a Boston-based preclinical contract research organization (CRO) that specializes in the development and execution of efficacy studies in mouse and rat disease models. It provides preclinical animal models and clinically relevant disease models to evaluate novel therapeutics, offering a start-to-finish solution from initial inquiry to study execution and data delivery.

blood/sample analysiscellular and molecular characterizationELISAFlow Cytometrygene expression analysishistopathologyin-life monitoringin vitro and ex vivo assaysmicrobiology and microbiomemultiplex cytokine analysisRNA/DNA isolationsurgerytissue and sample processing

Bio-Val Consulting, LLC (BVC) is a woman-owned small business founded in 2013 by CEO Kristin H. Clement, Ph.D., dedicated to helping clients navigate assay development and validation and meet regulatory compliance for bioanalytical needs. It offers consulting on quantitative MOA-based bioassays supporting drug research and development, including antibody screening, characterization, potency and stability testing.

antibody purificationassay developmentassay validationbinding assayscAMP stimulation assayscell-based assaysddPCRECL (Meso Scale Discovery)ELISAELISpotFlow Cytometrylateral flow assay developmentneutralization assaysPCRphagocytosis assaysSDS-PAGE/Western Blot

Comparative Biosciences, Inc. (CBI) was founded in 1996 to provide preclinical toxicology, pharmacokinetics, efficacy, pharmacology, and histopathology services to the biomedical and biopharmaceutical community. CBI is AAALAC accredited and registered with the FDA, USDA and OLAW, and operates a purpose-built facility in Sunnyvale, California with an in-house histopathology laboratory and full-time quality assurance unit.

CT scanningdigital radiographyELISAhistopathologyimmunohistochemistryin situ hybridizationlaser DopplerMRIoptical coherence tomographyPCRpharmacokineticspreclinical toxicologyultrasound

CD BioSciences is a CRO focused on oncology testing, translational research and clinical diagnostics. It provides advanced pathology services, molecular diagnostic platforms and end-to-end lab solutions including central lab services, preclinical and nonclinical studies, and clinical and regulatory support to accelerate precision medicine development.

AI-assisted image analysisbiobankingcentral laboratory servicesdPCRFISHFlow Cytometryhistopathologyimmunohistochemistry (IHC)liquid biopsy/ctDNAMRD testingmultiplex IHC/IFNGSRegulatory consultingSanger sequencingwhole slide imaging

Open menuGenomics + AIYour All-in-One eDNA Species Monitoring PlatformHarness the power of environmental DNA, geospatial data and AI to identify thousands of organisms, demonstrate your impact, meet regulations, and make data-driven management decisions.Get in TouchExplore a Projectapp.ednaexplorer.org/explore/organismsOUR SERVICESYour copilot for eDNA projectsEND TO ENDFull Service Project SupportFrom planning to lab to analysis, we help you get results from your eDNA-powered biodiversity projects.Book a DemoAnalysis Software with Great UXOur intuitive platform makes complex genetic and geospatial data come alive to ecologists, managers, land owners and researchers alike.Learn more →Global Insight with a Local FootprintWe partner with vetted local labs internationally for processing, ensuring your samples are kept safe in country.Learn more →Data Sovereignty and Controlled SharingYou.

Bioinformaticsdata analysisddPCR lab analysisgeospatial data integrationmetabarcodingpredictive modelingreporting

Eviogen Discovery is an innovation-driven Contract Research Organization (CRO) established in 2016, offering integrated drug discovery services and customized bio solutions to pharma, biotech, life-science industries and research organizations. It provides services from target discovery to lead candidate selection, including target ID and validation, hit-to-lead, lead optimization, and in-vitro safety and toxicology studies, with flexible FFS or FTE business models.

assay biologyFlow Cytometryhigh content imagingin vitro ADMEin vivo PKmedicinal chemistrynext-generation sequencingprotein expression and purificationscreeningSPR (Biacore)stable cell line generation

Evolve Genomix is a genomics company making genomic technologies accessible for agriculture, food safety, and public health. It offers rapid diagnostics and high-throughput sequencing, including rapid field-use test kits and targeted metagenomics, and is an NSF SBIR Phase I grant winner for rapid pathogen detection technology.

assay and device developmentBioinformaticshigh-throughput sequencingmicrobial genome sequencingnext-generation sequencingrapid diagnosticstargeted metagenomics

Franklin Biolabs is a genetic medicines and biologics Contract Research Organization (CRO) offering services from discovery to commercial approval, including vector production, analytical testing, preclinical studies, pharmacology and toxicology assessments, pathology, immunology, and bioanalytical services. It produces research-grade AAV, lentiviral, and adenoviral vectors and provides scalable AAV vector production for preclinical and clinical stages.

AAV vector manufacturingadenoviral vector productionadherent and suspension-based productionanalytical testingbiodistribution studieschromatography purificationGLP toxicologyhistologyimmunogenicity assessmentlarge-scale manufacturinglentiviral vector productionmultiplex in situ hybridizationplasmid design and optimizationprocess developmentviral shedding analysis

GeneCopoeia, Inc. is a U.S.-based functional genomics company founded in 1999 that develops products and services for genomics, proteomics, and molecular and cellular biology. It is the original manufacturer of ORF cDNA clones for human and mouse and offers sequence-verified clones, CRISPR and TALEN tools, microRNA analysis products, and promoter reporters for biomedical research and pharmaceutical/diagnostic R&D.

AAV deliveryantigen microarray profilingcell line characterizationCRISPR genome editingcustom cloninggene synthesislentiviral deliverypeptide microarray profilingRNAiSanger sequencingstable cell line generation

Inpradica is a biotechnology contract research organization supporting scientific research through molecular biology, experimental workflows, bioinformatics, and computational data analysis. It offers expertise spanning molecular biology, assay development, bioinformatics, and computational analysis to support evidence-based research, with a clear process from R&D to commercialization.

assay developmentBioinformaticsbiotech consultingcomputational data analysisCRISPR gene editingcustom molecular assay development & validationELISAmetagenomicsmolecular biologyRNA-seq

iProcess has built one of the world’s most extensive biobanks and sample collection networks, capable of meeting the stringent needs of any disease research program. Whether using specimens for assay development, bench research, or generating big data for your research or development studies, we deliver.

assay developmentbiomarker validationbiorepository servicesbiospecimen collection and processingdigital pathology and AI image analysishistopathologyimmunohistochemistrymobile PBMC processingmolecular biologynucleic acid extraction and purificationPCR and RT-PCR

multiplex molecular solution for diagnosis of human diseases A multiplex molecular solution for diagnosis of human diseases Our Company KASA BIO is a molecular diagnostics company developing a proprietary high multiplex probe technology for the targeted detection of nucleic acid biomarkers. Our vision is to provide simple and inexpensive solutions for diagnosis of complex diseases using well adopted PCR technology. Founders have extensive experience in molecular biology and molecular diagnostics. Diagnostic Challenges Various infectious and oncological diagnostic applications require analysis of multiple DNA or RNA biomarkers. Lack of availability of a quantitative multiplex platform for analysis of gene expression and mi RNA signature analysis. Lack of availability of a tool for analysis of multiple biological specimens at resource limited setting. Requirement of larger sample volume.

digital PCRisothermal amplificationmolecular diagnosticsmultiplex probe technologynucleic acid biomarker detection